The bioinformatics market represents one of today's most compelling investment opportunities, with $31.71 billion in market value expanding at 13.4% CAGR through 2031. For business leaders, this isn't just another emerging technology—it's a strategic imperative that will define competitive advantage in healthcare, pharmaceuticals, and biotechnology over the next decade. The...